Lung Cancer Deaths Among American Indians and Alaska Natives, 1990-2009

Lung Cancer Deaths Among American Indians and Alaska Natives, 1990-2009
复制标题

DOI:
10.2105/ajph.2013.301609
复制
发表时间:
2014-06-01
影响因子:
12.7
通讯作者:
Rhodes, Kris
Rhodes, Kris
中科院分区:
医学2区
文献类型:
--
作者:
Plescia, Marcus;Henley, Sarah Jane;Rhodes, Kris

文献摘要

被引文献

相似文献

目标。我们使用关联数据集检查了美洲印第安人/阿拉斯加原住民(AI/ANs)肺癌的区域差异,以尽量减少种族错误分类。基于1999年至2009年联邦肺癌发病率数据和1990年至2009年与印第安人健康服务(IHS)登记记录相关的死亡数据,我们按IHS地区计算了非西班牙裔AI/AN和白人的年龄调整发病率和死亡率,重点关注合同医疗服务提供区(CHSDA)县。我们将死亡率与吸烟流行率联系起来,并计算死亡率与发病率之比。CHSDA县AI/AN人群的肺癌死亡率因IHS区域而异,从北部平原的94.0 / 10万到西南地区的15.2 / 10万,反映了吸烟与肺癌之间的强烈相关性。每诊断出100例肺癌,非洲裔/非洲裔人的死亡人数比白人多6人。1997年AI/AN男性的肺癌死亡率开始下降,而AI/AN女性的肺癌死亡率仍在上升。非洲裔/非洲裔人口与白人人口区域肺癌死亡率的比较表明,在烟草控制和预防干预方面存在差异。应努力确保AI/AN人员从当前和新出现的肺癌预防和控制干预措施中获得平等利益。
Objectives. We examined regional differences in lung cancer among American Indians/Alaska Natives (AI/ANs) using linked data sets to minimize racial misclassification.Methods. On the basis of federal lung cancer incidence data for 1999 to 2009 and deaths for 1990 to 2009 linked with Indian Health Service (IHS) registration records, we calculated age-adjusted incidence and death rates for non-Hispanic AI/AN and White persons by IHS region, focusing on Contract Health Service Delivery Area (CHSDA) counties. We correlated death rates with cigarette smoking prevalence and calculated mortality-to-incidence ratios.Results. Lung cancer death rates among AI/AN persons in CHSDA counties varied across IHS regions, from 94.0 per 100 000 in the Northern Plains to 15.2 in the Southwest, reflecting the strong correlation between smoking and lung cancer. For every 100 lung cancers diagnosed, there were 6 more deaths among AI/AN persons than among White persons. Lung cancer death rates began to decline in 1997 among AI/AN men and are still increasing among AI/AN women.Conclusions. Comparison of regional lung cancer death rates between AI/AN and White populations indicates disparities in tobacco control and prevention interventions. Efforts should be made to ensure that AI/AN persons receive equal benefit from current and emerging lung cancer prevention and control interventions.